zolbetuximab
astellas
[]
spotlight - folfox +/- zolbe
1l her2- mgc/gej #gi23 38.5% cldn+ mpfs 10.6v8.6m hr 0.75 mos 18.2v15.5m hr 0.75 orr 60% in both n,v w/ zolbe a new soc for her2-
question will be io vs zolbe?
- stratify by pdl1?
congrats to etal 
Cancer Doctor, Professor, Lifelong Learner #GI #Cancer 🇨🇦 @UBC @BCCancer @CCTG #Prez @CAMO #TEDxSpeaker #MedTwitter @OncoAlert Tweets are my own